AC Immune Ltd buy melinda
Start price
02.11.17
/
50%
€10.91
Target price
03.01.18
€16.24
Performance (%)
10.79%
End price
03.01.18
€12.09
Summary
This prediction ended on 03.01.18 with a price of €12.09. The prediction had a final performance of 10.79%. melinda has a follow-up prediction for AC Immune Ltd where he still thinks AC Immune Ltd is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
AC Immune Ltd | 16.241% | 16.241% | -24.662% | 1.767% |
iShares Core DAX® | -0.581% | -2.940% | 23.930% | 88.105% |
iShares Nasdaq 100 | 0.824% | 3.718% | 16.923% | 81.110% |
iShares Nikkei 225® | -0.630% | 5.126% | 10.243% | 36.476% |
iShares S&P 500 | 0.643% | 2.253% | 11.312% | 53.999% |
According to melinda what are the pros and cons of AC Immune Ltd for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread AC Immune Ltd diskutieren
Biotechnologie und medizinische SecteurRecherche
AC Immune SA ist ein klinisches Praktikum biopharmazeutisches Unternehmen, die sich in qui zwei proprietäre Technologieplattformen nutzen zu entdecken, Konstruktion und Entwicklung von neuartigen, proprietären Medikamente zur Prävention, Diagnose und Behandlung von neurodegenerativen Erkrankungen mit Fehlfaltung von Proteinen assoziiert
(Vom Mitglied beendet)
Current prediction by melinda for AC Immune Ltd
AC Immune Ltd
Start price
Target price
Perf. (%)
€2.28
25.09.25
25.09.25
-
25.09.26
25.09.26
14.07%
12:09
12:09
Could be worthwhile Investment >10% per year
Stopped prediction by melinda for AC Immune Ltd
AC Immune Ltd
Start price
Target price
Perf. (%)
€1.41
13.04.25
13.04.25
-
13.04.26
13.04.26
3.82%
26.04.25
26.04.25
Could be worthwhile Investment >10% per year